For the latest media releases and news about Pharmaxis Ltd, please select from the following articles. Material news announcements made by Pharmaxis are first filed with the Australian Securities Exchange (ASX) and are also available on the ASX website.
Pharmaxis Ltd (ASX: PXS) will release its Quarterly Shareholder Update on the morning of 31 October 2023.
Investors and analysts are invited to participate in a virtual investor briefing by the Company’s chief executive officer Mr Gary Phillips at 10.00am AEDT on Tuesday 31 October 2023.
The event will consist of a short presentation of the Company’s progress over the past quarter and future plans followed by a Q&A session from attendees.
The event is free to attend, and investors should register in advance using the following registration link:
Upon registration, instructions for joining the session will be sent via email.
To ensure as many questions as possible can be responded to in the allotted time, Pharmaxis welcomes investors to pre-submit questions by emailing them to: firstname.lastname@example.orgRead full media release - pdf
The 2023 Annual General Meeting of Pharmaxis will be held as a virtual meeting on Tuesday, 28 November 2023 at 11:00 am (Sydney time).
The notice of meeting, explanatory statement and proxy form was made available to shareholders on 26 October 2023. The notice of meeting together with a sample proxy form is available here.
The 2023 statutory annual report is available here.